ZELECIMENT ROSTUDIRSEN
UNII DL5BCM4SFN

Substance Identification & Data

This profile provides standardized clinical and technical data for Zeleciment Rostudirsen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DL5BCM4SFN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2725863-42-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DL5BCM4SFN
CAS Registry Number
2725863-42-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZELECIMENT ROSTUDIRSEN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12543
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
NO-94
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zeleciment Rostudirsen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZELECIMENT ROSTUDIRSEN

Common Names & Synonyms

IMMUNOGLOBULIN FAB-G1KAPPA (VH-CH1_L-KAPPA), ANTI-(HOMO SAPIENS TFRC (TRANSFERRIN RECEPTOR, TFR1, TFR1, CD71)), MONOCLONAL ANTIBODY, CONJUGATED AT LYSINE RESIDUES WITH ROSTUDIRSEN GROUPS
IMMUNOGLOBULIN IGG1 FAB FRAGMENT, ANTI-(HUMAN AND MACACA FASCICULARIS TRANSFERRIN RECEPTORS TYPE 1) (HUMAN-MUS MUSCULUS MONOCLONAL F5298 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL F5298 .KAPPA.-CHAIN, N6-AMIDE WITH RNA (P-DEOXY-P-(DIMETHYLAMINO))(2',3'-DIDEOXY-2',3'-IMINO-2',3'-SECO)(2'A->5')(C-T-C-C-A-A-C-A-T-C-A-A-G-G-A-A-G-A-T-G-G-C-A-T-T-T-C-T-A-(2'A-ACETYL)G) 5'-(P-(4-(4-((2-AMINO-2-OXOETHYL)METHYLAMINO)-6-((6-((((4-((N-(3-(2-(2-(2-((5AS,6R,6AR)-6-(18-CARBOXY-3-OXO-2,7,10,13,16-PENTAOXA-4-AZAOCTADEC-1-YL)-1,4,5,5A,6,6A,7,8-OCTAHYDROCYCLOPROPA(5,6)CYCLOOCTA(1,2-D)-1,2,3-TRIAZOL-1-YL)ETHOXY)ETHOXY)ETHOXY)-1-OXOPROPYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)AMINO)HEXYL)OXY)-1,3,5-TRIAZIN-2-YL)-1-PIPERAZINYL)-N,N-DIMETHYLPHOSPHONAMIDATE)
ZELECIMENT ROSTUDIRSEN [INN]
ZELECIMENT ROSTUDIRSEN [USAN]

Technical Codes

DYNE-251
DYNE-251 FAB DRUG CONJUGATE